ACTRN12606000159550
Completed
未知
The feasibility of Continuous Positive Airway Pressure (CPAP) treatment for sleep disordered breathing in acute tetraplegia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Obstructive Sleep Apnoea (OSA) in acute tetraplegia
- Sponsor
- Institute for breathing and sleep
- Enrollment
- 18
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Acute tetraplegia. All American Spinal Injury Association (ASIA) classifications and lesion levels will be included.
Exclusion Criteria
- •Admission, physician diagnosis of significant head injury, significant pre\-existing respiratory or cardiac disease and any other significant co\-morbidity. An inability of provide informed consent. Planned hospital discharge within six weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The feasibility of continuous positive airway pressure ventilation in acute ischemic stroke patients: a pilot studycerebral infarctionischemic stroke1000796310046304NL-OMON48215OLVG10
Completed
Not Applicable
Evaluation of fixed continuous positive airway pressure (CPAP) with C-Flex+ against fixed CPAPObstructive sleep apnoeaNervous System DiseasesSleep disordersISRCTN04363711Philips Respironics (France)85
Completed
Not Applicable
Can early treatment prevent obstructive sleep apnoea-related brain damage?Moderate obstructive sleep apnoea (between 15 and 29 hypopnoea or apnoea events per hour during sleep).Sleep apnoea-related brain damage.Neurological - Other neurological disordersRespiratory - Sleep apnoeaACTRN12614001202651Dr. Carrie Innes45
Terminated
Not Applicable
Treatment of Obstructive Sleep Apnoea for Cognitive Decline in Mild Cognitive ImpairmentACTRN12614000442606niversity of Sydney29
Not yet recruiting
Not Applicable
Impact of prophylactic continuous positive airway pressure in the delivery room (DR-CPAP) on neonates <1500g in a low-resource setting: A feasibility trialPaediatricsPACTR202208462613789Mbale Clinical Research Institute100